Comorbidity Identification and Referral in Atopic Dermatitis: a Consensus Document.
Por:
Ortíz de Frutos J, Carretero G, de Lucas R, Puig S, Serra E, Gómez Castro S, Rebollo Laserna F, Loza E and Silvestre-Salvador JF
Publicada:
4 jul 2022
Ahead of Print:
18 abr 2022
Resumen:
BACKGROUND: Atopic dermatitis (AD) is associated with different comorbidities. OBJECTIVE: To develop evidence-based and practical recommendations for comorbidity detection in patients with AD in daily practice. METHODS: We employed a modified RAND/UCLA methodology, including a systematic literature review (SLR). A group of six experts on AD was established. We conducted a comprehensive search strategy on Medline, Embase, and Cochrane Library up to June 2020. The selection criteria included studies with AD patients with any comorbidity reporting data on comorbidity prevalence, burden, and management. The included studies quality was assessed. The SLR results were discussed in a nominal group meeting, and several recommendations were generated. The recommendation agreement grade was tested on additional experts through a Delphi process. RESULTS: The recommendations cover the following issues: 1) Which comorbidities should be investigated at the first and subsequent visits; 2) How and when should comorbidities be investigated (screening); 3) How should patients with specific comorbidities be referred to confirm their diagnosis and initiate management; 4) Specific recommendations to ensure an integral care approach for AD patients with any comorbidity. CONCLUSIONS: These recommendations seek to guide dermatologists, patients, and other stakeholders in regard to early comorbidity identification and AD patient referral to improve decision-making.
Filiaciones:
Ortíz de Frutos J:
Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
Carretero G:
Department of Dermatology, Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain
de Lucas R:
Department of Dermatology, Hospital Universitario La Paz, 28046 Madrid, Spain
Puig S:
Department of Dermatology, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Biomedical Research Networking Center on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain
:
Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Gómez Castro S:
Pfizer Medical Department, Alcobendas, Madrid, Spain
Rebollo Laserna F:
Pfizer Medical Department, Alcobendas, Madrid, Spain
Loza E:
Instituto de Salud Musculoesquelética, Madrid, Spain
:
Department of Dermatology, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-FISABIO Foundation), Alicante, Spain
Green Submitted
|